Glucose targets for preventing diabetic kidney disease and its progression

Author:

Ruospo Marinella12,Saglimbene Valeria M1,Palmer Suetonia C3,De Cosmo Salvatore4,Pacilli Antonio4,Lamacchia Olga5,Cignarelli Mauro5,Fioretto Paola6,Vecchio Mariacristina7,Craig Jonathan C89,Strippoli Giovanni FM191011

Affiliation:

1. Diaverum; Medical Scientific Office; Lund Sweden

2. Amedeo Avogadro University of Eastern Piedmont; Division of Nephrology and Transplantation, Department of Translational Medicine; Via Solaroli 17 Novara Italy 28100

3. University of Otago Christchurch; Department of Medicine; 2 Riccarton Ave PO Box 4345 Christchurch New Zealand 8140

4. Scientific Institute CSS; Department of Medicine; Viale Cappuccini San Giovanni Rotondo Italy 71013

5. University of Foggia; Department of Endocrinology; Foggia Italy

6. University of Padova; Department of Medicine; Padova Italy

7. Danone Research; RD 128 Palaiseau Cedex France 91767

8. The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006

9. The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145

10. University of Bari; Department of Emergency and Organ Transplantation; Bari Italy

11. Diaverum Academy; Bari Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Reference234 articles.

1. Effects of medical therapies on retinopathy progression in type 2 diabetes.[Erratum appears in N Engl J Med. 2011 Jan 13;364(2):190], [Erratum appears in N Engl J Med. 2012 Dec 20;367(25):2458];Chew;New England Journal of Medicine,2010

2. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods;Buse;American Journal of Cardiology,2007

3. Effects of intensive blood-pressure control in type 2 diabetes mellitus;Cushman;New England Journal of Medicine,2010

4. Long-term effects of intensive glucose lowering on cardiovascular outcomes;Gerstein;New England Journal of Medicine,2011

5. Effects of combination lipid therapy in type 2 diabetes mellitus.[Erratum appears in N Engl J Med. 2010 May 6;362(18):1748];Ginsberg;New England Journal of Medicine,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3